{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:33Z","timestamp":1790638653025,"version":"4.1.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12035-021-02603-7","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T13:03:54Z","timestamp":1635512634000},"page":"459-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders"],"prefix":"10.1007","volume":"59","author":[{"given":"P.","family":"Vatsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"4","key":"2603_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein AJ et al (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17(4):331\u201340","journal-title":"Transplantation"},{"key":"2603_CR2","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","volume":"9","author":"JR Ferreira","year":"2018","unstructured":"Ferreira JR et al (2018) Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol 9:2837","journal-title":"Front Immunol"},{"key":"2603_CR3","doi-asserted-by":"crossref","unstructured":"Eleuteri S, Fierabracci A (2019) Insights into the secretome of mesenchymal stem cells and its potential applications. Int J Mol Sci 20(18)","DOI":"10.3390\/ijms20184597"},{"issue":"4","key":"2603_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315\u20137","journal-title":"Cytotherapy"},{"key":"2603_CR5","doi-asserted-by":"crossref","unstructured":"Vizoso FJ et al. (2017) Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 18(9)","DOI":"10.3390\/ijms18091852"},{"key":"2603_CR6","doi-asserted-by":"crossref","unstructured":"Harrell CR et al. (2019) Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells, 8(5)","DOI":"10.3390\/cells8050467"},{"key":"2603_CR7","doi-asserted-by":"crossref","unstructured":"Ferreira JR et al. (2018) Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Frontiers in Immunology, 9(2837)","DOI":"10.3389\/fimmu.2018.02837"},{"key":"2603_CR8","doi-asserted-by":"crossref","unstructured":"Taus F et al. (2019) Platelet-derived extracellular vesicles as target of antiplatelet agents. What is the evidence? Front Pharmacol, 10: 1256","DOI":"10.3389\/fphar.2019.01256"},{"issue":"4","key":"2603_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373\u2013383","journal-title":"J Cell Biol"},{"key":"2603_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-016-0811-2","volume":"14","author":"F Felicetti","year":"2016","unstructured":"Felicetti F et al (2016) Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med 14:56","journal-title":"J Transl Med"},{"issue":"30","key":"2603_CR11","doi-asserted-by":"publisher","first-page":"29877","DOI":"10.18632\/oncotarget.4924","volume":"6","author":"G Ding","year":"2015","unstructured":"Ding G et al (2015) Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget 6(30):29877\u201329888","journal-title":"Oncotarget"},{"issue":"1","key":"2603_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0021-9258(17)34997-9","volume":"166","author":"E Chargaff","year":"1946","unstructured":"Chargaff E, West R (1946) The biological significance of the thromboplastic protein of blood. J Biol Chem 166(1):189\u2013197","journal-title":"J Biol Chem"},{"issue":"3","key":"2603_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","volume":"13","author":"P Wolf","year":"1967","unstructured":"Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13(3):269\u2013288","journal-title":"Br J Haematol"},{"key":"2603_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fnins.2016.00127","volume":"10","author":"M Basso","year":"2016","unstructured":"Basso M, Bonetto V (2016) Extracellular vesicles and a novel form of communication in the brain. Front Neurosci 10:127","journal-title":"Front Neurosci"},{"key":"2603_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fneur.2019.00211","volume":"10","author":"OY Bang","year":"2019","unstructured":"Bang OY, Kim EH (2019) Mesenchymal stem cell-derived extracellular vesicle therapy for stroke: challenges and progress. Front Neurol 10:211","journal-title":"Front Neurol"},{"key":"2603_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255\u2013289","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2603_CR17","doi-asserted-by":"crossref","unstructured":"Margolis L, Sadovsky Y (2019) The biology of extracellular vesicles: the known unknowns. PLoS Biol, 17(7): e3000363","DOI":"10.1371\/journal.pbio.3000363"},{"issue":"4","key":"2603_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213\u2013228","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2603_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M et al (2019) Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 21(1):9\u201317","journal-title":"Nat Cell Biol"},{"key":"2603_CR20","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo M et al (2015) Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066","journal-title":"J Extracell Vesicles"},{"key":"2603_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1479-5876-9-86","volume":"9","author":"S Keller","year":"2011","unstructured":"Keller S et al (2011) Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 9:86","journal-title":"J Transl Med"},{"key":"2603_CR22","doi-asserted-by":"crossref","unstructured":"Guiot J et al. (2019) Exosomal miRNAs in lung diseases: from biologic function to therapeutic targets. J Clin Med, 8(9)","DOI":"10.3390\/jcm8091345"},{"key":"2603_CR23","doi-asserted-by":"crossref","unstructured":"Jaquenod De Giusti C, Santalla M, Das S (2019) Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health. J Mol Cell Cardiol, 137: 143\u2013151","DOI":"10.1016\/j.yjmcc.2019.09.016"},{"key":"2603_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2018.11.009","volume":"488","author":"L Console","year":"2019","unstructured":"Console L, Scalise M, Indiveri C (2019) Exosomes in inflammation and role as biomarkers. Clin Chim Acta 488:165\u2013171","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2603_CR25","doi-asserted-by":"publisher","first-page":"1599680","DOI":"10.1080\/20013078.2019.1599680","volume":"8","author":"LT Vu","year":"2019","unstructured":"Vu LT et al (2019) Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b. J Extracell Vesicles 8(1):1599680","journal-title":"J Extracell Vesicles"},{"issue":"10","key":"2603_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","volume":"15","author":"R Xu","year":"2018","unstructured":"Xu R et al (2018) Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol 15(10):617\u2013638","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"2603_CR27","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCRESAHA.117.309681","volume":"120","author":"D Todorova","year":"2017","unstructured":"Todorova D et al (2017) Extracellular vesicles in angiogenesis. Circ Res 120(10):1658\u20131673","journal-title":"Circ Res"},{"key":"2603_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","volume":"1416","author":"M Gnecchi","year":"2016","unstructured":"Gnecchi M et al (2016) Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol 1416:123\u2013146","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2603_CR29","doi-asserted-by":"publisher","first-page":"1609206","DOI":"10.1080\/20013078.2019.1609206","volume":"8","author":"KW Witwer","year":"2019","unstructured":"Witwer KW et al (2019) Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles 8(1):1609206","journal-title":"J Extracell Vesicles"},{"key":"2603_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-014-0260-8","volume":"12","author":"M Madrigal","year":"2014","unstructured":"Madrigal M, Rao KS, Riordan NH (2014) A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med 12:260","journal-title":"J Transl Med"},{"issue":"3","key":"2603_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai RC et al (2010) Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res 4(3):214\u2013222","journal-title":"Stem Cell Res"},{"key":"2603_CR32","doi-asserted-by":"publisher","first-page":"1073140","DOI":"10.1155\/2016\/1073140","volume":"2016","author":"M Nawaz","year":"2016","unstructured":"Nawaz M et al (2016) Extracellular vesicles: evolving factors in stem cell biology. Stem Cells Int 2016:1073140","journal-title":"Stem Cells Int"},{"issue":"5","key":"2603_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mt.2015.44","volume":"23","author":"S Rani","year":"2015","unstructured":"Rani S et al (2015) Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther 23(5):812\u2013823","journal-title":"Mol Ther"},{"key":"2603_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fncel.2017.00055","volume":"11","author":"Y Yang","year":"2017","unstructured":"Yang Y et al (2017) MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Front Cell Neurosci 11:55","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"2603_CR35","doi-asserted-by":"publisher","first-page":"C621","DOI":"10.1152\/ajpcell.00228.2013","volume":"306","author":"G Turturici","year":"2014","unstructured":"Turturici G et al (2014) Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol 306(7):C621\u2013C633","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"2603_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K et al (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31(10):890\u2013896","journal-title":"Exp Hematol"},{"issue":"3","key":"2603_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000124281","volume":"35","author":"JM Gimble","year":"2008","unstructured":"Gimble JM et al (2008) In vitro differentiation potential of mesenchymal stem cells. Transfus Med Hemother 35(3):228\u2013238","journal-title":"Transfus Med Hemother"},{"issue":"5","key":"2603_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.leu.2404132","volume":"20","author":"J Ratajczak","year":"2006","unstructured":"Ratajczak J et al (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20(5):847\u2013856","journal-title":"Leukemia"},{"issue":"6","key":"2603_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654\u2013659","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2603_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi M et al (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11(4):367\u2013368","journal-title":"Nat Med"},{"key":"2603_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2015.02.005","volume":"40","author":"DK Kim","year":"2015","unstructured":"Kim DK et al (2015) EVpedia: a community web resource for prokaryotic and eukaryotic extracellular vesicles research. Semin Cell Dev Biol 40:4\u20137","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"2603_CR42","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","volume":"428","author":"S Keerthikumar","year":"2016","unstructured":"Keerthikumar S et al (2016) ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol 428(4):688\u2013692","journal-title":"J Mol Biol"},{"issue":"D1","key":"2603_CR43","doi-asserted-by":"publisher","first-page":"D516","DOI":"10.1093\/nar\/gky1029","volume":"47","author":"M Pathan","year":"2019","unstructured":"Pathan M et al (2019) Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res 47(D1):D516\u2013D519","journal-title":"Nucleic Acids Res"},{"key":"2603_CR44","doi-asserted-by":"crossref","unstructured":"Latifkar A et al. (2019) New insights into extracellular vesicle biogenesis and function. J Cell Sci, 132(13)","DOI":"10.1242\/jcs.222406"},{"issue":"4","key":"2603_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.stem.2013.09.007","volume":"13","author":"GN Stacey","year":"2013","unstructured":"Stacey GN et al (2013) Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells? Cell Stem Cell 13(4):385\u2013388","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2603_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4252\/wjsc.v12.i3.168","volume":"12","author":"M Scopetti","year":"2020","unstructured":"Scopetti M et al (2020) Mesenchymal stem cells in neurodegenerative diseases: opinion review on ethical dilemmas. World J Stem Cells 12(3):168\u2013177","journal-title":"World J Stem Cells"},{"issue":"2","key":"2603_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick P et al (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11(2):150\u2013156","journal-title":"Lancet Neurol"},{"issue":"4","key":"2603_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1352458517703802","volume":"24","author":"JA Cohen","year":"2018","unstructured":"Cohen JA et al (2018) Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Mult Scler 24(4):501\u2013511","journal-title":"Mult Scler"},{"issue":"8","key":"2603_CR49","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.neurobiolaging.2014.01.028","volume":"35","author":"HJ Park","year":"2014","unstructured":"Park HJ et al (2014) Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model. Neurobiol Aging 35(8):1920\u20131928","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2603_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/NRL.0000000000000188","volume":"23","author":"D Mendes Filho","year":"2018","unstructured":"Mendes Filho D et al (2018) Therapy with mesenchymal stem cells in Parkinson disease: history and perspectives. Neurologist 23(4):141\u2013147","journal-title":"Neurologist"},{"issue":"1","key":"2603_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13643-021-01736-z","volume":"10","author":"A Karimi","year":"2021","unstructured":"Karimi A et al (2021) Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson\u2019s disease: a systematic review protocol. Syst Rev 10(1):188","journal-title":"Syst Rev"},{"issue":"3","key":"2603_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrn.2015.29","volume":"17","author":"V Budnik","year":"2016","unstructured":"Budnik V, Ruiz-Canada C, Wendler F (2016) Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci 17(3):160\u2013172","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2603_CR53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tins.2018.03.006","volume":"41","author":"MM Holm","year":"2018","unstructured":"Holm MM, Kaiser J, Schwab ME (2018) Extracellular vesicles: multimodal envoys in neural maintenance and repair. Trends Neurosci 41(6):360\u2013372","journal-title":"Trends Neurosci"},{"key":"2603_CR54","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fnmol.2019.00240","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu W et al (2019) Role of exosomes in central nervous system diseases. Front Mol Neurosci 12:240","journal-title":"Front Mol Neurosci"},{"key":"2603_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fnmol.2017.00276","volume":"10","author":"F Ciregia","year":"2017","unstructured":"Ciregia F, Urbani A, Palmisano G (2017) Extracellular vesicles in brain tumors and neurodegenerative diseases. Front Mol Neurosci 10:276","journal-title":"Front Mol Neurosci"},{"issue":"33","key":"2603_CR56","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.2174\/1381612825666191014164950","volume":"25","author":"D Upadhya","year":"2019","unstructured":"Upadhya D, Shetty AK (2019) Extracellular vesicles as therapeutics for brain injury and disease. Curr Pharm Des 25(33):3500\u20133505","journal-title":"Curr Pharm Des"},{"issue":"12","key":"2603_CR57","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/stem.1409","volume":"31","author":"H Xin","year":"2013","unstructured":"Xin H et al (2013) MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31(12):2737\u20132746","journal-title":"Stem Cells"},{"key":"2603_CR58","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbi.2016.11.011","volume":"60","author":"K Drommelschmidt","year":"2017","unstructured":"Drommelschmidt K et al (2017) Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun 60:220\u2013232","journal-title":"Brain Behav Immun"},{"issue":"5","key":"2603_CR59","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0271678X17708917","volume":"38","author":"L Otero-Ortega","year":"2018","unstructured":"Otero-Ortega L et al (2018) Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage. J Cereb Blood Flow Metab 38(5):767\u2013779","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"2603_CR60","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","volume":"138","author":"LA Gomes","year":"2019","unstructured":"Gomes LA et al (2019) Abeta-induced acceleration of Alzheimer-related tau-pathology spreading and its association with prion protein. Acta Neuropathol 138(6):913\u2013941","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2603_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-019-0317-5","volume":"14","author":"LS Watson","year":"2019","unstructured":"Watson LS et al (2019) Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer\u2019s disease. Mol Neurodegener 14(1):22","journal-title":"Mol Neurodegener"},{"issue":"5","key":"2603_CR62","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH et al (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161(5):1869\u20131879","journal-title":"Am J Pathol"},{"issue":"30","key":"2603_CR63","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L et al (2006) Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 103(30):11172\u201311177","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2603_CR64","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1096\/fj.07-9357com","volume":"22","author":"RA Sharples","year":"2008","unstructured":"Sharples RA et al (2008) Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J 22(5):1469\u20131478","journal-title":"FASEB J"},{"issue":"25","key":"2603_CR65","doi-asserted-by":"publisher","first-page":"18197","DOI":"10.1074\/jbc.M609475200","volume":"282","author":"V Vingtdeux","year":"2007","unstructured":"Vingtdeux V et al (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J Biol Chem 282(25):18197\u201318205","journal-title":"J Biol Chem"},{"issue":"8","key":"2603_CR66","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"MB Dinkins","year":"2014","unstructured":"Dinkins MB et al (2014) Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 35(8):1792\u20131800","journal-title":"Neurobiol Aging"},{"issue":"33","key":"2603_CR67","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","volume":"36","author":"MB Dinkins","year":"2016","unstructured":"Dinkins MB et al (2016) Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer\u2019s disease pathology and improves cognition in the 5XFAD mouse. J Neurosci 36(33):8653\u20138667","journal-title":"J Neurosci"},{"issue":"6","key":"2603_CR68","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/nan.12042","volume":"39","author":"RO Carare","year":"2013","unstructured":"Carare RO et al (2013) Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol 39(6):593\u2013611","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2603_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clinbiochem.2019.08.005","volume":"73","author":"R Matej","year":"2019","unstructured":"Matej R, Tesar A, Rusina R (2019) Alzheimer\u2019s disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview. Clin Biochem 73:26\u201331","journal-title":"Clin Biochem"},{"key":"2603_CR70","doi-asserted-by":"crossref","unstructured":"Serrano-Pozo A et al. (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med, 1(1): a006189.","DOI":"10.1101\/cshperspect.a006189"},{"issue":"11","key":"2603_CR71","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584\u20131593","journal-title":"Nat Neurosci"},{"issue":"1","key":"2603_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/intimm\/dxx002","volume":"29","author":"LC Liew","year":"2017","unstructured":"Liew LC et al (2017) Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer\u2019s disease. Int Immunol 29(1):11\u201319","journal-title":"Int Immunol"},{"key":"2603_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neures.2018.08.005","volume":"141","author":"S Takeda","year":"2019","unstructured":"Takeda S (2019) Progression of Alzheimer\u2019s disease, tau propagation, and its modifiable risk factors. Neurosci Res 141:36\u201342","journal-title":"Neurosci Res"},{"issue":"2","key":"2603_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/genes4020152","volume":"4","author":"L Urbanelli","year":"2013","unstructured":"Urbanelli L et al (2013) Signaling pathways in exosomes biogenesis, secretion and fate. Genes (Basel) 4(2):152\u2013170","journal-title":"Genes (Basel)"},{"key":"2603_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.arr.2016.05.001","volume":"32","author":"E Eitan","year":"2016","unstructured":"Eitan E et al (2016) Impact of lysosome status on extracellular vesicle content and release. Ageing Res Rev 32:65\u201374","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2603_CR76","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13195-020-00623-4","volume":"12","author":"X Gallart-Palau","year":"2020","unstructured":"Gallart-Palau X et al (2020) Alzheimer\u2019s disease progression characterized by alterations in the molecular profiles and biogenesis of brain extracellular vesicles. Alzheimers Res Ther 12(1):54","journal-title":"Alzheimers Res Ther"},{"issue":"14","key":"2603_CR77","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","volume":"287","author":"K Yuyama","year":"2012","unstructured":"Yuyama K et al (2012) Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J Biol Chem 287(14):10977\u201310989","journal-title":"J Biol Chem"},{"issue":"35","key":"2603_CR78","doi-asserted-by":"publisher","first-page":"24488","DOI":"10.1074\/jbc.M114.577213","volume":"289","author":"K Yuyama","year":"2014","unstructured":"Yuyama K et al (2014) Decreased amyloid-beta pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J Biol Chem 289(35):24488\u201324498","journal-title":"J Biol Chem"},{"issue":"1","key":"2603_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-2010-1206","volume":"19","author":"A Bulloj","year":"2010","unstructured":"Bulloj A et al (2010) Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease. J Alzheimers Dis 19(1):79\u201395","journal-title":"J Alzheimers Dis"},{"issue":"48","key":"2603_CR80","doi-asserted-by":"publisher","first-page":"37405","DOI":"10.1074\/jbc.M110.149468","volume":"285","author":"IY Tamboli","year":"2010","unstructured":"Tamboli IY et al (2010) Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J Biol Chem 285(48):37405\u201337414","journal-title":"J Biol Chem"},{"issue":"4","key":"2603_CR81","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341\u2013345","journal-title":"Nat Biotechnol"},{"key":"2603_CR82","doi-asserted-by":"crossref","unstructured":"Campos CR et al. (2020) Brain shuttle neprilysin reduces central amyloid-beta levels. PLoS One. 15(3): e0229850","DOI":"10.1371\/journal.pone.0229850"},{"key":"2603_CR83","doi-asserted-by":"crossref","first-page":"8102478","DOI":"10.1155\/2016\/8102478","volume":"2016","author":"M Ahmed Nel","year":"2016","unstructured":"Ahmed Nel M et al (2016) Therapeutic potential of dental pulp stem cell secretome for Alzheimer\u2019s disease treatment: an in vitro study. Stem Cells Int 2016:8102478","journal-title":"Stem Cells Int"},{"key":"2603_CR84","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/srep01197","volume":"3","author":"T Katsuda","year":"2013","unstructured":"Katsuda T et al (2013) Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3:1197","journal-title":"Sci Rep"},{"issue":"6","key":"2603_CR85","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1074\/jbc.M117.807180","volume":"293","author":"MA de Godoy","year":"2018","unstructured":"de Godoy MA et al (2018) Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-beta oligomers. J Biol Chem 293(6):1957\u20131975","journal-title":"J Biol Chem"},{"key":"2603_CR86","doi-asserted-by":"publisher","first-page":"971907","DOI":"10.1155\/2012\/971907","volume":"2012","author":"RC Lai","year":"2012","unstructured":"Lai RC et al (2012) Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics. 2012:971907","journal-title":"Int J Proteomics."},{"issue":"3","key":"2603_CR87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.15171\/apb.2016.041","volume":"6","author":"D Pashoutan Sarvar","year":"2016","unstructured":"Pashoutan Sarvar D, Shamsasenjan K, Akbarzadehlaleh P (2016) Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy. Adv Pharm Bull 6(3):293\u2013299","journal-title":"Adv Pharm Bull"},{"key":"2603_CR88","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.043","volume":"182","author":"B Yu","year":"2015","unstructured":"Yu B et al (2015) Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182:349\u2013360","journal-title":"Int J Cardiol"},{"issue":"11","key":"2603_CR89","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","volume":"33","author":"H Xin","year":"2013","unstructured":"Xin H et al (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33(11):1711\u20131715","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"2603_CR90","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1046\/j.1460-9568.2000.00164.x","volume":"12","author":"T Harkany","year":"2000","unstructured":"Harkany T et al (2000) beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12(8):2735\u20132745","journal-title":"Eur J Neurosci"},{"issue":"16","key":"2603_CR91","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1021\/jm200544q","volume":"54","author":"Y Cheng","year":"2011","unstructured":"Cheng Y et al (2011) From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1). J Med Chem 54(16):5836\u20135857","journal-title":"J Med Chem"},{"issue":"1","key":"2603_CR92","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","volume":"76","author":"HF Dovey","year":"2001","unstructured":"Dovey HF et al (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76(1):173\u2013181","journal-title":"J Neurochem"},{"issue":"1","key":"2603_CR93","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","volume":"39","author":"IV Kurochkin","year":"2018","unstructured":"Kurochkin IV, Guarnera E, Berezovsky IN (2018) Insulin-degrading enzyme in the fight against Alzheimer\u2019s disease. Trends Pharmacol Sci 39(1):49\u201358","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"2603_CR94","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","volume":"48","author":"O Pivovarova","year":"2016","unstructured":"Pivovarova O et al (2016) Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer\u2019s disease? Ann Med 48(8):614\u2013624","journal-title":"Ann Med"},{"key":"2603_CR95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2018.08.028","volume":"686","author":"M Becker","year":"2018","unstructured":"Becker M et al (2018) Neprilysin degrades murine Amyloid-beta (Abeta) more efficiently than human Abeta: further implication for species-specific amyloid accumulation. Neurosci Lett 686:74\u201379","journal-title":"Neurosci Lett"},{"issue":"9","key":"2603_CR96","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF et al (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38(9):1205\u20131235","journal-title":"Acta Pharmacol Sin"},{"key":"2603_CR97","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.addr.2021.04.027","volume":"174","author":"D Buschmann","year":"2021","unstructured":"Buschmann D, Mussack V, Byrd JB (2021) Separation, characterization, and standardization of extracellular vesicles for drug delivery applications. Adv Drug Deliv Rev 174:348\u2013368","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"2603_CR98","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2603_CR99","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ejn.14269","volume":"49","author":"RN Rees","year":"2019","unstructured":"Rees RN, Noyce AJ, Schrag A (2019) The prodromes of Parkinson\u2019s disease. Eur J Neurosci 49(3):320\u2013327","journal-title":"Eur J Neurosci"},{"key":"2603_CR100","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcell.2020.00086","volume":"8","author":"H Yu","year":"2020","unstructured":"Yu H et al (2020) Potential roles of exosomes in Parkinson\u2019s disease: from pathogenesis, dsiagnosis, and treatment to prognosis. Front Cell Dev Biol 8:86","journal-title":"Front Cell Dev Biol"},{"issue":"35","key":"2603_CR101","doi-asserted-by":"publisher","first-page":"14075","DOI":"10.1523\/JNEUROSCI.0692-13.2013","volume":"33","author":"RR Lalchandani","year":"2013","unstructured":"Lalchandani RR et al (2013) Dopamine D2 receptors regulate collateral inhibition between striatal medium spiny neurons. J Neurosci 33(35):14075\u201314086","journal-title":"J Neurosci"},{"issue":"12","key":"2603_CR102","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","volume":"67","author":"L Alvarez-Erviti","year":"2010","unstructured":"Alvarez-Erviti L et al (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67(12):1464\u20131472","journal-title":"Arch Neurol"},{"issue":"3","key":"2603_CR103","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L et al (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42(3):360\u2013367","journal-title":"Neurobiol Dis"},{"issue":"20","key":"2603_CR104","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE et al (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797\u20138807","journal-title":"J Neurosci"},{"issue":"2","key":"2603_CR105","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-0854.2008.00853.x","volume":"10","author":"T Ben Gedalya","year":"2009","unstructured":"Ben Gedalya T et al (2009) Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling. Traffic 10(2):218\u2013234","journal-title":"Traffic"},{"issue":"20","key":"2603_CR106","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E et al (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838\u20136851","journal-title":"J Neurosci"},{"issue":"5","key":"2603_CR107","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","volume":"290","author":"M Grey","year":"2015","unstructured":"Grey M et al (2015) Acceleration of alpha-synuclein aggregation by exosomes. J Biol Chem 290(5):2969\u20132982","journal-title":"J Biol Chem"},{"key":"2603_CR108","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-9-18","volume":"9","author":"CR Overk","year":"2014","unstructured":"Overk CR et al (2014) Hippocampal neuronal cells that accumulate alpha-synuclein fragments are more vulnerable to Abeta oligomer toxicity via mGluR5\u2013implications for dementia with Lewy bodies. Mol Neurodegener 9:18","journal-title":"Mol Neurodegener"},{"issue":"Pt 2","key":"2603_CR109","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A et al (2016) Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain 139(Pt 2):481\u2013494","journal-title":"Brain"},{"issue":"5","key":"2603_CR110","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14(5):501\u2013503","journal-title":"Nat Med"},{"issue":"5","key":"2603_CR111","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH et al (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14(5):504\u2013506","journal-title":"Nat Med"},{"key":"2603_CR112","doi-asserted-by":"publisher","first-page":"641157","DOI":"10.3389\/fnins.2021.641157","volume":"15","author":"J He","year":"2021","unstructured":"He J et al (2021) Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke. Front Neurosci 15:641157","journal-title":"Front Neurosci"},{"issue":"3","key":"2603_CR113","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A et al (2014) Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75(3):351\u2013362","journal-title":"Ann Neurol"},{"issue":"10","key":"2603_CR114","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"Zhuang X et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19(10):1769\u20131779","journal-title":"Mol Ther"},{"key":"2603_CR115","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","volume":"287","author":"M Qu","year":"2018","unstructured":"Qu M et al (2018) Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson\u2019s disease. J Control Release 287:156\u2013166","journal-title":"J Control Release"},{"key":"2603_CR116","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ et al (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 207:18\u201330","journal-title":"J Control Release"},{"issue":"1","key":"2603_CR117","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","volume":"9","author":"R Kojima","year":"2018","unstructured":"Kojima R et al (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment. Nat Commun 9(1):1305","journal-title":"Nat Commun"},{"key":"2603_CR118","doi-asserted-by":"crossref","unstructured":"Vilaca-Faria H, Salgado AJ, Teixeira FG (2019) Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson's disease? Cells, 8(2)","DOI":"10.3390\/cells8020118"},{"issue":"1","key":"2603_CR119","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13287-019-1445-0","volume":"10","author":"E Mianehsaz","year":"2019","unstructured":"Mianehsaz E et al (2019) Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther 10(1):340","journal-title":"Stem Cell Res Ther"},{"key":"2603_CR120","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","volume":"67","author":"Z Li","year":"2019","unstructured":"Li Z et al (2019) Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol 67:268\u2013280","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2603_CR121","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4252\/wjsc.v12.i5.323","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020) Advances in treatment of neurodegenerative diseases: perspectives for combination of stem cells with neurotrophic factors. World J Stem Cells 12(5):323\u2013338","journal-title":"World J Stem Cells"},{"issue":"10","key":"2603_CR122","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1007\/s12035-020-02006-0","volume":"57","author":"CS Rajpurohit","year":"2020","unstructured":"Rajpurohit CS et al (2020) Mechanistic insights of astrocyte-mediated hyperactive autophagy and loss of motor neuron function in SOD1(L39R) linked amyotrophic lateral sclerosis. Mol Neurobiol 57(10):4117\u20134133","journal-title":"Mol Neurobiol"},{"key":"2603_CR123","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-1-4939-8722-1_15","volume-title":"Physician's field guide to neuropsychology","author":"JS Katz","year":"2019","unstructured":"Katz JS, Woolley SC (2019) Amyotrophic lateral sclerosis. Physician\u2019s field guide to neuropsychology. Springer, pp 255\u2013265"},{"key":"2603_CR124","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fneur.2019.00229","volume":"10","author":"RH Chipika","year":"2019","unstructured":"Chipika RH et al (2019) Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front Neurol 10:229","journal-title":"Front Neurol"},{"issue":"5796","key":"2603_CR125","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133","journal-title":"Science"},{"issue":"5","key":"2603_CR126","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00401-011-0805-3","volume":"121","author":"K Forsberg","year":"2011","unstructured":"Forsberg K et al (2011) Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 121(5):623\u2013634","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2603_CR127","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","volume":"33","author":"S Saberi","year":"2015","unstructured":"Saberi S et al (2015) Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin 33(4):855\u2013876","journal-title":"Neurol Clin"},{"issue":"1","key":"2603_CR128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2007.09.024","volume":"428","author":"C Gomes","year":"2007","unstructured":"Gomes C et al (2007) Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett 428(1):43\u201346","journal-title":"Neurosci Lett"},{"issue":"22","key":"2603_CR129","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.1074\/jbc.M112.425066","volume":"288","author":"M Basso","year":"2013","unstructured":"Basso M et al (2013) Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 288(22):15699\u201315711","journal-title":"J Biol Chem"},{"issue":"39","key":"2603_CR130","doi-asserted-by":"publisher","first-page":"16398","DOI":"10.1073\/pnas.1102645108","volume":"108","author":"LI Grad","year":"2011","unstructured":"Grad LI et al (2011) Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci 108(39):16398\u201316403","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"2603_CR131","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1073\/pnas.1017275108","volume":"108","author":"C M\u00fcnch","year":"2011","unstructured":"M\u00fcnch C, O\u2019Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci 108(9):3548\u20133553","journal-title":"Proc Natl Acad Sci"},{"key":"2603_CR132","doi-asserted-by":"crossref","unstructured":"Massenzio F et al. (2018) Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1864(12): 3771\u20133785","DOI":"10.1016\/j.bbadis.2018.10.013"},{"issue":"10","key":"2603_CR133","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1074\/jbc.RA118.004825","volume":"294","author":"JM Silverman","year":"2019","unstructured":"Silverman JM et al (2019) CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1) G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem 294(10):3744\u20133759","journal-title":"J Biol Chem"},{"issue":"1","key":"2603_CR134","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T et al (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4(1):124\u2013134","journal-title":"Cell Rep"},{"key":"2603_CR135","doi-asserted-by":"crossref","unstructured":"Rutherford NJ et al. (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS genetics, 4(9): e1000193","DOI":"10.1371\/journal.pgen.1000193"},{"issue":"18","key":"2603_CR136","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka T et al (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 18(18):3353\u20133364","journal-title":"Hum Mol Genet"},{"issue":"27","key":"2603_CR137","doi-asserted-by":"publisher","first-page":"24178","DOI":"10.18632\/oncotarget.4680","volume":"6","author":"X Ding","year":"2015","unstructured":"Ding X et al (2015) Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget 6(27):24178","journal-title":"Oncotarget"},{"issue":"5\u20136","key":"2603_CR138","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E et al (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15(5\u20136):351\u2013356","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"4","key":"2603_CR139","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1083\/jcb.201504057","volume":"211","author":"MS Feiler","year":"2015","unstructured":"Feiler MS et al (2015) TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol 211(4):897\u2013911","journal-title":"J Cell Biol"},{"issue":"12","key":"2603_CR140","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi Y et al (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139(12):3187\u20133201","journal-title":"Brain"},{"issue":"10","key":"2603_CR141","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","volume":"9","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. The Lancet Neurology 9(10):995\u20131007","journal-title":"The Lancet Neurology"},{"key":"2603_CR142","doi-asserted-by":"crossref","unstructured":"Kamelgarn M et al. (2016) Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1862(10): 2004\u20132014","DOI":"10.1016\/j.bbadis.2016.07.015"},{"key":"2603_CR143","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fnins.2017.00591","volume":"11","author":"S Forostyak","year":"2017","unstructured":"Forostyak S, Sykova E (2017) Neuroprotective potential of cell-based therapies in ALS: from bench to bedside. Front Neurosci 11:591","journal-title":"Front Neurosci"},{"issue":"6","key":"2603_CR144","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13543784.2019.1627324","volume":"28","author":"SA Goutman","year":"2019","unstructured":"Goutman SA et al (2019) Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opin Investig Drugs 28(6):525\u2013543","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"2603_CR145","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/stem.1812","volume":"32","author":"S Forostyak","year":"2014","unstructured":"Forostyak S et al (2014) Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS. Stem cells 32(12):3163\u20133172","journal-title":"Stem cells"},{"issue":"2","key":"2603_CR146","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.imlet.2015.08.007","volume":"168","author":"A Laroni","year":"2015","unstructured":"Laroni A, de Rosbo NK, Uccelli A (2015) Mesenchymal stem cells for the treatment of neurological diseases: immunoregulation beyond neuroprotection. Immunol Lett 168(2):183\u2013190","journal-title":"Immunol Lett"},{"issue":"2","key":"2603_CR147","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s12035-014-8716-7","volume":"51","author":"MP Kashyap","year":"2015","unstructured":"Kashyap MP et al (2015) Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity. Mol Neurobiol 51(2):791\u2013807","journal-title":"Mol Neurobiol"},{"key":"2603_CR148","doi-asserted-by":"crossref","unstructured":"Zhang L, Dong Z-F, Zhang J.-Y (2020) Immunomodulatory role of mesenchymal stem cells in Alzheimer's disease. Life Sciences, 246: 117405","DOI":"10.1016\/j.lfs.2020.117405"},{"key":"2603_CR149","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2016.01.061","volume":"320","author":"MA Lopez-Verrilli","year":"2016","unstructured":"Lopez-Verrilli MA et al (2016) Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience 320:129\u2013139","journal-title":"Neuroscience"},{"issue":"1","key":"2603_CR150","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.yexcr.2015.12.009","volume":"340","author":"R Bonafede","year":"2016","unstructured":"Bonafede R et al (2016) Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res 340(1):150\u2013158","journal-title":"Exp Cell Res"},{"key":"2603_CR151","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3389\/fnins.2019.01070","volume":"13","author":"E Calabria","year":"2019","unstructured":"Calabria E et al (2019) Ascs-exosomes recover coupling efficiency and mitochondrial membrane potential in an in vitro model of als. Front Neurosci 13:1070","journal-title":"Front Neurosci"},{"issue":"9","key":"2603_CR152","doi-asserted-by":"publisher","first-page":"e14072","DOI":"10.14814\/phy2.14072","volume":"7","author":"G Maguire","year":"2019","unstructured":"Maguire G et al (2019) Rescue of degenerating neurons and cells by stem cell released molecules: using a physiological renormalization strategy. Physiological Reports 7(9):e14072","journal-title":"Physiological Reports"},{"issue":"1","key":"2603_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-81039-4","volume":"11","author":"D Giunti","year":"2021","unstructured":"Giunti D et al (2021) Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation. Sci Rep 11(1):1\u201317","journal-title":"Sci Rep"},{"issue":"1","key":"2603_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0832-2","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) Stem cell-derived mitochondria transplantation: a novel strategy and the challenges for the treatment of tissue injury. Stem Cell Res Ther 9(1):1\u201310","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"2603_CR155","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/stem.2856","volume":"36","author":"K Hayakawa","year":"2018","unstructured":"Hayakawa K et al (2018) Protective effects of endothelial progenitor cell-derived extracellular mitochondria in brain endothelium. Stem Cells 36(9):1404\u20131410","journal-title":"Stem Cells"},{"issue":"10","key":"2603_CR156","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","volume":"4","author":"TR Doeppner","year":"2015","unstructured":"Doeppner TR et al (2015) Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med 4(10):1131\u20131143","journal-title":"Stem Cells Transl Med"},{"issue":"46","key":"2603_CR157","doi-asserted-by":"publisher","first-page":"74537","DOI":"10.18632\/oncotarget.12902","volume":"7","author":"K-H Chen","year":"2016","unstructured":"Chen K-H et al (2016) Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget 7(46):74537","journal-title":"Oncotarget"},{"issue":"1","key":"2603_CR158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"JY Lee","year":"2016","unstructured":"Lee JY et al (2016) Microvesicles from brain-extract\u2014treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke. Sci Rep 6(1):1\u201314","journal-title":"Sci Rep"},{"issue":"1","key":"2603_CR159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"J Fafi\u00e1n-Labora","year":"2017","unstructured":"Fafi\u00e1n-Labora J et al (2017) Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles. Sci Rep 7(1):1\u201312","journal-title":"Sci Rep"},{"issue":"3","key":"2603_CR160","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/stem.2756","volume":"36","author":"R Kulkarni","year":"2018","unstructured":"Kulkarni R et al (2018) Intercellular transfer of microvesicles from young mesenchymal stromal cells rejuvenates aged murine hematopoietic stem cells. Stem Cells 36(3):420\u2013433","journal-title":"Stem Cells"},{"issue":"1","key":"2603_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-19211-6","volume":"8","author":"JM Cha","year":"2018","unstructured":"Cha JM et al (2018) Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells. Sci Rep 8(1):1\u201316","journal-title":"Sci Rep"},{"issue":"5","key":"2603_CR162","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12975-017-0599-2","volume":"9","author":"RL Webb","year":"2018","unstructured":"Webb RL et al (2018) Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model. Transl Stroke Res 9(5):530\u2013539","journal-title":"Transl Stroke Res"},{"issue":"5","key":"2603_CR163","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/STROKEAHA.117.020353","volume":"49","author":"RL Webb","year":"2018","unstructured":"Webb RL et al (2018) Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke. Stroke 49(5):1248\u20131256","journal-title":"Stroke"},{"key":"2603_CR164","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuint.2016.08.003","volume":"111","author":"Y Zhang","year":"2017","unstructured":"Zhang Y et al (2017) Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int 111:69\u201381","journal-title":"Neurochem Int"},{"issue":"4","key":"2603_CR165","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3171\/2014.11.JNS14770","volume":"122","author":"Y Zhang","year":"2015","unstructured":"Zhang Y et al (2015) Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 122(4):856\u2013867","journal-title":"J Neurosurg"},{"issue":"1","key":"2603_CR166","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1073\/pnas.1522297113","volume":"113","author":"D-K Kim","year":"2016","unstructured":"Kim D-K et al (2016) Chromatographically isolated CD63+ CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI. Proc Natl Acad Sci 113(1):170\u2013175","journal-title":"Proc Natl Acad Sci"},{"key":"2603_CR167","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnins.2019.00014","volume":"13","author":"H Ni","year":"2019","unstructured":"Ni H et al (2019) Exosomes derived from bone mesenchymal stem cells ameliorate early inflammatory responses following traumatic brain injury. Front Neurosci 13:14","journal-title":"Front Neurosci"},{"key":"2603_CR168","doi-asserted-by":"crossref","unstructured":"Oses C et al. (2017) Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: potential application in the treatment of diabetic neuropathy. PLoS One, 12(5): e0178011.","DOI":"10.1371\/journal.pone.0178011"},{"issue":"15","key":"2603_CR169","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1089\/scd.2012.0029","volume":"21","author":"J Jones","year":"2012","unstructured":"Jones J et al (2012) Human adipose stem cell\u2013conditioned medium increases survival of Friedreich\u2019s Ataxia cells submitted to oxidative stress. Stem cells and development 21(15):2817\u20132826","journal-title":"Stem cells and development"},{"key":"2603_CR170","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1479-5876-9-47","volume":"9","author":"TS Chen","year":"2011","unstructured":"Chen TS et al (2011) Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med 9:47","journal-title":"J Transl Med"},{"key":"2603_CR171","doi-asserted-by":"crossref","unstructured":"Harrell CR et al. (2021) Mesenchymal stem cell-derived exosomes as new remedy for the treatment of neurocognitive disorders. Int J Mol Sci, 22(3)","DOI":"10.3390\/ijms22031433"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02603-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02603-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02603-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T02:03:50Z","timestamp":1726020230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02603-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2603"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02603-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Yes, all the authors have given their consent to the scientific contents and authorship to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Yes, all the authors have given their consent for the publication of this manuscript in its present form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}